• Home
  • Profile
    • About Us
    • Mission, Vision & Values
    • Exports
    • Future Plans
    • Corporate Social Responsibility
  • Strength
    • Quality
    • Research & Development
    • Facility
  • Products
    • Oral - Liquid Syrup & Suspension
    • Liquid Injectable (SVP)-Vials & Ampoules
    • Cephalosporin - Dry Powder Injections
    • Cephalosporin – Oral Solid
    • Lyophilised Injections (In Vials)
  • Gallery
    • Facility
    • Products
  • Prestigious Clients
  • Business Enquiry
  • Investor
    • Announcement
    • Annual Report
    • Compliances
    • Financial Results
    • Notices and Intimations
    • Policies
    • Prospectus
    • Shareholding Pattern
    • Investor Help Desk
    • Committees
    • Board of Directors
    • Registrar And Transfer Agent
    • Corporate Governance Report
    • Shareholders Meeting
  • Careers
  • Contact

    Corporate Governance Report

Corporate Governance Report

  • CGR-Q3 - Dec 2020
  • CGR-Q2 - Sept 2020
  • CGR-Q1 - June 2020
  • CGR-Q4 - March 2020
  • CGR-Q3 - Dec 2019
  • CGR-Q2 - Sept 2019
  • CGR-Q1 - June 2019
  • Home
  • Prestigious Clients
  • Careers
  • Gallery
  • Enquiry
  • Contact Us
  • Sitemap
    Profile
  • About Us
  • Vision & mission
  • Exports
  • Future Plans
  • Corporate Social Responsibility
    Strength
  • Quality
  • Research & Development
  • Facility
    Products
  • Oral - Liquid Syrup & Suspension
  • Liquid Injectable (SVP)-Vials & Ampoules - EU GMP Approved
  • Cephalosporin - Dry Powder Injections
  • Cephalosporin – Oral Solid
  • Lyophilised Injections (In Vials) - EU GMP Approved